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Abstract	
Type 2 diabetes mellitus (T2DM) has a tremendous impact on 
individual and societal healthcare costs. This requires 
improvements upon the first line intervention of lifestyle 
modifications such as weight management, physical activity, and 
nutritious dietary choices. Therefore, in an attempt to provide 
practitioners with a solitary intervention to advocate to their 
patients, this review will assess how a low-carbohydrate ketogenic 
diet (LCDK) compares to physical activity in adults (18-75 years 
old) with a BMI > 25 and T2DM with regards to management of 
glucose control indices. 
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Introduction	
Literature Search (November 2018): 
•  T2DM + low carbohydrate ketogenic diet 
•  T2DM + aerobic physical activity  
Databases: 
•  PubMed, ClinicalKey, Google Scholar  
•  7 articles used  
Inclusion Criteria Demographics: 
•  Adults 18-75 years old, with BMI >25, and T2DM 
Outcomes measurements: 
•  Glucose control, weight management, or quality of life	
	
Overview: Optimal management of type 2 diabetes mellitus is a 
multifactorial approach including physical activity, weight 
management, and good dietary habits. While this review favored a 
low carbohydrate ketogenic diet, it is hard to determine the 
sustainability of a low carbohydrate ketogenic diet past several 
months based on these studies. Additionally, physical activity may 
play more of a role in preventing and reducing T2DM risk factors, or 
slow its pathogenesis, rather than changing indices like HbA1c. 
Furthermore, there were not as many studies available to 
conclusively say dietary changes are superior to aerobic physical 
activity. 
Limitations: 
•  There are no comparative studies between single diet vs 
specific form of physical activity  
•  Greater than or equal to 50% of the participants in this study 
were women 
•  Timelines varied 8-36 weeks making it hard to determine the 
commitment a standard patient will have for an intervention	
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•  Both an increase in physical activity and a LCKD had significant 
improvements in outcomes measures 
•  Lifestyle modifications should be viewed and promoted more as 
a first-line intervention, not as a first-line recommendation. 
•  Overall, better results were seen with LCKD, so clinicians may 
want to focus on promoting a diet with <50g carbohydrates/daily 
in patients with T2DM 
•  However, the synergistic effects of dietary and lifestyle 
interventions should still be emphasized	
Conclusion	
 
Takeaways: 
•  In all LCKD studies one or more outcome 
measurements were significantly improved 
•  LCKD improved HbA1c by at least 0.5% up to 1.0% 
which is deemed clinically significant  
•  There was no significant change in HbA1c 
in either exercise study 
•  Oral antihyperglycemic medications can be reduced 
or eliminated after the implementation of the LCKD 
•  Westman et al observed medication 
changes in 95.2% of its participants 
(p<0.01) 
•  Aerobic physical activity for 90 minutes x 8 weeks 
reduced weight, anthropometry/BMI, while improving 
IR and plasma insulin (Motahari-Tabari et al) 
Methods	
Results		
Overview: 
•  10% of US adults have diabetes 
•  90% of diabetes cases are T2DM 
•  Nearly 1 in 3 adults are classified as pre-diabetic 
Diagnosis & Monitoring:  
•  Hemoglobin A1c (HbA1c), fasting blood sugar (FBS), plasma insulin 
(PI), insulin resistance (IR), weight management 
Management: 
•  1st line= Lifestyle modification (diet and physical activity) 
•  2nd line= Oral antihyperglycemic medications 
•  3rd line= injectable medications or insulin 
Consequences of uncontrolled T2DM: 
•  Risk of: neuropathy, blindness, amputation, coronary artery disease, 
stroke, kidney disease 
•  Increased costs to individual and healthcare 
Table 1: Comparison of Results 
Study HgA1c FBS PI IR Med. 
Dose 
Change 
Anthro-
pometry*
* 
Church et 
al (2010)* 
NS N/A N/A N/A NS NS 
Motahari-
Tabari et al 
(2014)* 
N/A S S S NS S 
Ebbeling 
et al 
(2018) 
N/A N/A N/A N/A N/A S 
Goday 
(2016) 
S S NS NS S S 
Saslow et 
al (2014) 
S NS NS NS S S 
Saslow et 
al (2017) 
S N/A N/A N/A N/A S 
Westman 
et al 
(2008) 
S S S N/A S S 
Key: S = significant (p≤ 0.05); NS = not significant; N/A=not available; 
*=Aerobic physical activity study; 
**Anthropometry included one or more of the following metrics: 
weight loss, BMI, waist circumference, hip circumference 
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